国际肿瘤学杂志 ›› 2021, Vol. 48 ›› Issue (6): 354-357.doi: 10.3760/cma.j.cn371439-20201119-00067

• 综述 • 上一篇    下一篇

新型免疫检查点在肿瘤治疗中的作用

吴远玲, 寿伟臻()   

  1. 上海中医药大学附属龙华医院胸外科 200032
  • 收稿日期:2020-11-19 修回日期:2020-12-26 出版日期:2021-06-08 发布日期:2021-06-24
  • 通讯作者: 寿伟臻 E-mail:shouweizhen@sina.com

Role of new immune checkpoints in tumor treatment

Wu Yuanling, Shou Weizhen()   

  1. Department of Thoracic Surgery, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2020-11-19 Revised:2020-12-26 Online:2021-06-08 Published:2021-06-24
  • Contact: Shou Weizhen E-mail:shouweizhen@sina.com

摘要:

新型免疫检查点靶标如淋巴细胞激活基因-3、T细胞免疫球蛋白黏蛋白-3、T细胞免疫球蛋白和ITIM结构域、T细胞活化的V结构域免疫球蛋白、B7同系物3、B和T淋巴细胞弱化子在肿瘤治疗中具有重要作用,阻断它们可延缓肿瘤生长、增强免疫细胞抗肿瘤作用、提高宿主存活率,虽然这些新型免疫检查点处于研究的早期阶段,但随着科技的不断发展,其在肿瘤免疫治疗中将发挥越来越重要的作用。

关键词: 肿瘤, 治疗, 免疫检查点

Abstract:

New immune checkpoint targets such as lymphocyte activation gene-3, T-cell immunoglobulin mucin-3, T cell immunoglobulin and ITIM domain, V-domain immunoglobulin suppressor of T cell activation, B7 Homolog 3, B and T lymphocyte attenuator play an important role in tumor treatment. Blocking them can delay tumor growth, enhance the anti-tumor effect of immune cells, and improve the survival rate of the host. Although these new immune checkpoints are in the early stages of research, with the continuous development of science and technology, they will play an increasingly important role in tumor immunotherapy.

Key words: Neoplasms, Therapy, Immune checkpoint